FGM Survey - What do you need to know?
Research status
Completed
Overview of Study
A 10 minute survey for doctors, nurses and other health service providers on the training and data collection needs related to female genital mutilation/cutting.
Follow up of women with low grade abnormalities of the cervix
Research status
Completed
Overview of Study
Progression and regression of low-grade epithelial abnormalities of the cervix
CUPID - Contraceptive Use Pregnancy Intention and Decisions Study
Research status
Completed
Overview of Study
The CUPID (Contraceptive Use, Pregnancy Intention and Decisions) research team is looking for young women aged 18-23 years from NSW to complete a short online survey about young women's experiences of contraception use and plans for pregnancy
Knowledge and use of emergency contraception by women seeking abortion
Research status
Completed
Overview of Study
Knowledge and use of emergency contraception among women seeking termination of pregnancy in New South Wales
Effect of vaginal contraceptive rings on vaginal mucosa
Research status
Completed
Overview of Study
A study to look for changes in vaginal and cervical appearance of women using contraceptive rings.
The Australian Collaboration for Chlamydia Enhanced Sentinel
Research status
Completed
Overview of Study
The Australian Collaboration for Chlamydia Enhanced Sentinel
Low Dose Mirena Study
Research status
Completed
Overview of Study
Ultra Low Dose Levonorgesterol Intrauterine Contraceptive System (IUS) Study
Dysfunctional Uterine Bleeding Study
Research status
Completed
Overview of Study
Dysfunctional Uterine Bleeding Study
A dose finding study of an intra uterine contraceptive system releasing the progestogen Nestorone
Research status
Completed
Overview of Study
A detailed analysis of menstrual blood loss in women using Norplant and Nestorone progestogen-only contraceptive implants or vaginal rings
Safety of Carrageenan microbicidal gel
Research status
Completed
Overview of Study
A study to determine the safety and acceptability of vaginal gel formulation PC-503 among low risk, abstinent women.
